STUDY ON EVALUATION OF SERUM GAMMA-GLUTAMYL TRANSFERASE (GGT) LEVELS IN ACUTE CORONARY SYNDROME-Reference-Cited by-同舟云学术

STUDY ON EVALUATION OF SERUM GAMMA-GLUTAMYL TRANSFERASE (GGT) LEVELS IN ACUTE CORONARY SYNDROME

Published:2021-04-01 Issue: Volume: Page:39-40
ISSN:
Container-title:INDIAN JOURNAL OF APPLIED RESEARCH
language:en
Short-container-title:IJAR

Author:

Dhanju Avtar Singh¹,Singla Deepshikha²,Singh Pashaura³,Chhabra Ajay³,Kaur Sukhraj⁴

Affiliation:

1. Associate Professor Dept. of Medicine Government Medical College, Amritsar.

2. Junior Resident, Dept. of Medicine, Government Medical College, Amritsar.

3. Associate Professor, Dept. of Medicine, Government Medical College, Amritsar

4. Assistant Professor, Department of Biochemistry, Government Medical College, Amritsar.

Abstract

Aim: The present study was undertaken with the aim to evaluate serum Gamma Glutamyl Transferase (GGT) levels in patients of acute coronary syndrome. Methodology: This cross-sectional study was conducted on 50 cases with acute coronary syndrome (Group A) and 50 healthy control subjects (Group B) meeting inclusion and exclusion criteria. Results: There is signicant rise in serum GGT levels in patients presenting with ACS in Group A as compared to Group B. Conclusion: Higher levels of GGT in ACS patients with risk factors such as hypertension, dyslipidemia and smoking may serve as biomarker to predict the occurrence of ACS.

Publisher

World Wide Journals

Reference17 articles.

1. Grech ED, Ramsdale DR. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. BMJ. 2003;326(7401):1259-61.

2. Chan MY, Du X, Eccleston D, Ma C, Mohanan PP, Ogita M, et al. Acute coronary syndrome in the Asia-Pacific region. Int J Cardiol. 2016;202:861-9.

3. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, et al. CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371(9622):1435-42.

4. Moran AE, Forouzanfar MH, Roth G, Mensah GA, Ezzati M, Flaxman A, et al. The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study. Circulation. 2014;129:1493–1501.

5. Truelsen T, Krarup LH, Iversen HK, Mensah GA, Feigin VL, Sposato LA, et al. . (2015). Causes of death data in the global burden of disease estimates for ischemic and hemorrhagic stroke. Neuroepidemioogy 2015;45:152–160.